NewsPublic Affairs / January 7, 2019

$100M Expansion Of Pharmaceutical Operations Set For Indiana

$100M Expansion Of Pharmaceutical Operations Set For Indiana

The state of Indiana and the city of Bloomington announced Monday that Somerset, New Jersey-based Catalent Inc. plans a "significant expansion."

Nyttend/public domain

BLOOMINGTON, Ind. (AP) — A company is moving forward on a $100 million expansion of its pharmaceutical manufacturing operations in southern Indiana.

The state of Indiana and the city of Bloomington announced Monday that Somerset, New Jersey-based Catalent Inc. plans a "significant expansion" of its manufacturing of biologics, which are drugs made from living cells instead of chemicals. The expansion in Bloomington includes creating up to 200 new jobs by the end of 2024.

The maker of drug delivery technologies is working to expand drug substance manufacturing capacity and other capacity due to projected growth.

Catalent already employs about 900 people in Bloomington.

The Indiana Economic Development Corp. has offered Catalent up to $2.4 million in conditional tax credits based on the company's job creation plans. The city of Bloomington is considering additional incentives.

At WFYI, our goal is to cover stories that matter to you. Our reporting is rooted in facts. It considers all perspectives and is available to everyone. We don't have paywalls, but we do need support. So if unbiased, trusted journalism is important to you, please join us. Donate now.

 

 

Related News

Judge Blocks New Indiana Panhandling Law From Taking Effect
New Laws Take Effect July 1
Utilities Ordered To Keep The Lights On Until Aug. 14 Despite Unpaid Bills